World Health Expo 2026: BD Highlights Latest Advances in MedTech Solutions
Published: 10 Feb 2026
Author: Precedence Research
BD (Becton, Dickinson and Company) (NYSE: BDX), a global leader in medical technology, is showcasing its latest innovations from the Connected Care segment at World Health Expo (WHX Dubai 2026). The company will highlight solutions ranging from AI-enabled technologies to pharmacy automation, emphasizing digital adoption, patient safety, and smarter clinical decision-making. Featured at BD’s booth (S15.B10) are its next-generation Advanced Patient Monitoring (APM) systems, including HemoSphere Stream™, VitaWave Plus™ Cuff, and the HemoSphere Alta™ monitor.
“Our presence at World Health Expo Dubai 2026 underscores BD’s commitment to advancing innovations that elevate patient care,” said Nazih Darwish, newly appointed President for Middle East, Turkey & Africa at BD. “Through our advanced patient monitoring systems and intelligent medication management platforms, we provide clinicians with connected, data-driven solutions that improve safety, streamline workflows, and deliver better outcomes. As healthcare across the region embraces digital transformation, BD continues to be a trusted partner in building a more connected, efficient, and sustainable future of care.”
The European Society of Anesthesiology and Intensive Care emphasizes the growing importance of non-invasive hemodynamic monitoring in patient care, highlighting the need for accurate, continuous, and reliable measurements. BD’s VitaWave Plus System addresses this need by providing precise, non-invasive blood pressure monitoring that can be accessed wherever a compatible patient monitor is available, enabling clinicians to make timely and informed decisions.
Making its first appearance at the expo, the HemoSphere Alta Monitor is equipped with advanced smart and predictive parameters, designed to detect early signs of hemodynamic instability before critical events occur. This proactive approach empowers clinicians to intervene sooner, improving patient outcomes and enhancing the ability to manage complex cases efficiently. Together, these innovations reflect BD’s focus on combining cutting-edge technology with practical clinical applications to support safer, more effective patient care.
BD’s Incada platform aims to integrate data across compatible BD devices, offering enterprise-wide visibility, AI-driven insights, and advanced security for managing controlled substances efficiently.
At WHX Dubai 2026, BD is also showcasing how its innovation strategy is guided by its Signature Programmes, which tackle the healthcare industry’s most pressing challenges, including patient safety, workforce sustainability, and operational efficiency.
Visitors to BD’s booth can interact with experts, witness live demonstrations of globally debuting technologies, and explore how connected, intelligent solutions are transforming healthcare delivery across the GCC and beyond. World Health Expo Dubai, formerly Arab Health, has for over 50 years served as the premier hub where healthcare professionals, products, and ideas converge to shape the future of global care.